OTCMKTS:OXBDF - Oxford BioMedica Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$0.2120 0.00 (0.00 %)
(As of 05/28/2018 06:00 AM ET)
Previous Close$0.2120
Today's Range$0.2120 - $0.2120
52-Week Range$0.0613 - $0.45
Volume4,000 shs
Average Volume86,643 shs
Market Capitalization$696.16 million
P/E RatioN/A
Dividend YieldN/A
Beta1.19

About Oxford BioMedica (OTCMKTS:OXBDF)

Oxford BioMedica logoOxford BioMedica plc, a biopharmaceutical company, researches, develops, and produces gene and cell therapy products for the treatment of ocular, neurodegenerative, and cancer diseases in Europe and rest of world. The company operates through Partnering and R&D segments. Its LentiVector platform technology integrates genes into non-dividing cells in the brain and the eye, as well as accommodates multiple therapeutic genes. The company's products under development include OXB-102 that has completed Phase I/II trial for the treatment of Parkinson's disease; OXB-202, which is in a Phase I/IIa trial preparation for the prevention of corneal graft rejection; OXB-301, a cancer vaccine which is in a Phase I/II trial; and OXB-302, which is based on an autologous T-cell that is engineered using a lentiviral vector to express a chimeric antigen receptor targeting multiple cancers, as well as OXB-201 that is in Phase I/II trial for the treatment of ?wet' age-related macular degeneration and diabetic retinopathy. It is also developing SAR 422459 that is in a Phase II trial for the treatment of Stargardt disease; and SAR 421869, a gene-based therapy that is in Phase I/II trial for the treatment of Usher syndrome 1B. The company has partnerships with Sanofi, GlaxoSmithKline, Novartis, Green Cross LabCell, and Immune Design Corp. Oxford BioMedica plc was founded in 1995 and is headquartered in Oxford, the United Kingdom.

Receive OXBDF News and Ratings via Email

Sign-up to receive the latest news and ratings for OXBDF and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Private households
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:OXBDF
CUSIPN/A
Phone44-18-6578-3000

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$37.67 million
Price / Sales18.48
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares3,283,790,000

Oxford BioMedica (OTCMKTS:OXBDF) Frequently Asked Questions

What is Oxford BioMedica's stock symbol?

Oxford BioMedica trades on the OTCMKTS under the ticker symbol "OXBDF."

Who are some of Oxford BioMedica's key competitors?

Who are Oxford BioMedica's key executives?

Oxford BioMedica's management team includes the folowing people:
  • Mr. John Dawson, CEO & Exec. Director (Age 58)
  • Mr. Peter Nolan, Chief Bus. Officer & Exec. Director (Age 65)
  • Mr. Timothy William Watts, Exec. Officer (Age 60)
  • Mr. Stuart Paynter, CFO & Director
  • Dr. James Miskin Ph.D., Chief Technology Officer

Has Oxford BioMedica been receiving favorable news coverage?

News stories about OXBDF stock have trended somewhat positive on Monday, according to Accern Sentiment Analysis. Accern identifies negative and positive press coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Oxford BioMedica earned a daily sentiment score of 0.18 on Accern's scale. They also assigned media coverage about the company an impact score of 46.85 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future.

How do I buy shares of Oxford BioMedica?

Shares of OXBDF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Oxford BioMedica's stock price today?

One share of OXBDF stock can currently be purchased for approximately $0.2120.

How big of a company is Oxford BioMedica?

Oxford BioMedica has a market capitalization of $696.16 million and generates $37.67 million in revenue each year.

How can I contact Oxford BioMedica?

Oxford BioMedica's mailing address is Windrush Court Transport Way, Oxford X0, OX4 6LT. The company can be reached via phone at 44-18-6578-3000.


MarketBeat Community Rating for Oxford BioMedica (OXBDF)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  30 (Vote Outperform)
Underperform Votes:  31 (Vote Underperform)
Total Votes:  61
MarketBeat's community ratings are surveys of what our community members think about Oxford BioMedica and other stocks. Vote "Outperform" if you believe OXBDF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OXBDF will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Oxford BioMedica (OTCMKTS:OXBDF) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
1 Wall Street analysts have issued ratings and price targets for Oxford BioMedica in the last 12 months. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

Oxford BioMedica (OTCMKTS:OXBDF) Consensus Price Target History

Price Target History for Oxford BioMedica (OTCMKTS:OXBDF)

Oxford BioMedica (OTCMKTS:OXBDF) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
10/31/2017HC WainwrightReiterated RatingBuyView Rating Details
12/5/2016Roth CapitalReiterated RatingBuyView Rating Details
(Data available from 5/28/2016 forward)

Earnings

Dividends

Oxford BioMedica (OTCMKTS:OXBDF) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Oxford BioMedica (OTCMKTS OXBDF) Insider Trading and Institutional Ownership History

Insider Trading History for Oxford BioMedica (OTCMKTS:OXBDF)

Oxford BioMedica (OTCMKTS OXBDF) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)

Headlines

Oxford BioMedica (OTCMKTS OXBDF) News Headlines

Source:
DateHeadline
Zacks Investment Research Lowers Oxford BioMedica (OXBDF) to HoldZacks Investment Research Lowers Oxford BioMedica (OXBDF) to Hold
www.americanbankingnews.com - May 16 at 11:29 AM
Analyzing Oxford BioMedica (OXBDF) & Absolute Software (ALSWF)Analyzing Oxford BioMedica (OXBDF) & Absolute Software (ALSWF)
www.americanbankingnews.com - May 16 at 10:58 AM
Edison Issues Outlook on Oxford BioMedica (OXB)Edison Issues Outlook on Oxford BioMedica (OXB)
finance.yahoo.com - May 10 at 10:43 AM
Oxford BioMedica (OXBDF) Rating Increased to Hold at ValuEngineOxford BioMedica (OXBDF) Rating Increased to Hold at ValuEngine
www.americanbankingnews.com - May 2 at 10:58 PM
Oxford BioMedica (OXBDF) Stock Rating Upgraded by Zacks Investment ResearchOxford BioMedica (OXBDF) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - April 19 at 4:34 PM
Oxford BioMedica (OXBDF) Lifted to Buy at Zacks Investment ResearchOxford BioMedica (OXBDF) Lifted to Buy at Zacks Investment Research
www.americanbankingnews.com - April 13 at 8:25 AM
Oxford BioMedica (OXBDF) Cut to "Hold" at Zacks Investment ResearchOxford BioMedica (OXBDF) Cut to "Hold" at Zacks Investment Research
www.americanbankingnews.com - April 12 at 9:47 AM
Oxford Biomedica (OXBDF) Upgraded by Zacks Investment Research to BuyOxford Biomedica (OXBDF) Upgraded by Zacks Investment Research to Buy
www.americanbankingnews.com - April 6 at 6:29 PM
Oxford Biomedica (OXBDF) Lowered to "Hold" at Zacks Investment ResearchOxford Biomedica (OXBDF) Lowered to "Hold" at Zacks Investment Research
www.americanbankingnews.com - April 4 at 11:15 AM
Oxford Biomedica (OXBDF) Upgraded to "Buy" at Zacks Investment ResearchOxford Biomedica (OXBDF) Upgraded to "Buy" at Zacks Investment Research
www.americanbankingnews.com - April 3 at 7:49 AM
Oxford Biomedica (OXBDF) Downgraded by Zacks Investment Research to "Hold"Oxford Biomedica (OXBDF) Downgraded by Zacks Investment Research to "Hold"
www.americanbankingnews.com - April 2 at 5:18 PM
Oxford Biomedica (OXBDF) Lowered to Sell at ValuEngineOxford Biomedica (OXBDF) Lowered to Sell at ValuEngine
www.americanbankingnews.com - March 31 at 12:42 PM
Oxford Biomedica (OXBDF) Downgraded by Zacks Investment ResearchOxford Biomedica (OXBDF) Downgraded by Zacks Investment Research
www.americanbankingnews.com - March 24 at 12:16 PM
Oxford Biomedica (OXBDF) Upgraded to Buy by Zacks Investment ResearchOxford Biomedica (OXBDF) Upgraded to Buy by Zacks Investment Research
www.americanbankingnews.com - March 23 at 6:46 AM
Oxford Biomedica (OXBDF) to Post FY2022 Earnings of $0.01 Per Share, Jefferies Group ForecastsOxford Biomedica (OXBDF) to Post FY2022 Earnings of $0.01 Per Share, Jefferies Group Forecasts
www.americanbankingnews.com - March 19 at 9:48 AM
[$$] Pharma groups deliver mixed performance[$$] Pharma groups deliver mixed performance
finance.yahoo.com - February 16 at 9:51 AM
Who Owns Oxford BioMedica PLC (LON:OXB)?Who Owns Oxford BioMedica PLC (LON:OXB)?
finance.yahoo.com - January 26 at 8:30 AM
Oxford BioMedica PLC (LON:OXB): Has Recent Earnings Growth Beaten Long-Term Trend?Oxford BioMedica PLC (LON:OXB): Has Recent Earnings Growth Beaten Long-Term Trend?
finance.yahoo.com - December 20 at 10:14 AM

SEC Filings

Oxford BioMedica (OTCMKTS:OXBDF) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Oxford BioMedica (OTCMKTS OXBDF) Stock Chart for Monday, May, 28, 2018

Loading chart…

This page was last updated on 5/28/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.